RxDoctor Payments Data

Kyrieckos Aleck

Clinical Genetics (M.D.) · Albuquerque, NMNPI 1891767307

Payments from drug & device makers

$1,259,532in general payments, 2019–2025

Across 520 payments — averaging $2422.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$562K
  • Sanofi$280K
  • Shire North American Group Inc$189K
  • Chiesi USA, Inc.$106K
  • Ultragenyx Pharmaceutical Inc.$68K
  • AstraZeneca$17K
  • plus $39K from 6 others

What the payments were for

  • Consulting fees$55,82513%
  • Speaking & faculty fees$317,17074%
  • Travel & lodging$47,41511%
  • Food & beverage$8,6442%
  • Education$1640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical genetics (m.d.) providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Other clinical genetics (m.d.) in Albuquerque

Where these figures come from

Is this you, or does something look wrong? →